Inhibition of Lck: Evidence for a novel natural Src family kinase inhibitor

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Src family kinase (SFK) is a family of protein tyrosine kinases that play important roles in the development of various cancers. Here, we showed that a naturally occurring inhibitory factor of SFK can be extracted from the rat brain. This inhibitor strongly suppressed the activity of SFKs including Lck and Fyn. It did not inhibit other protein tyrosine kinases including Wee1 or serine/threonine kinases Mst2, Cdk5/p25, Cdk5/p35, and Cdk2/cyclin A. The inhibitor was not an ATPase, a phosphatase that dephosphorylates substrates of the SFK reaction, or a protease that degrades SFKs. Activity of mutant Lck with C-terminal tyrosine substituted with phenylalanine was also suppressed by the inhibitor to a similar extent of wild-type Lck, indicating that the inhibitor was not CSK. Gel filtration chromatography indicated that the molecular size of the prevalent form of this inhibitor was approximately 44kDa. © 2012 Informa UK, Ltd.

Author supplied keywords

Cite

CITATION STYLE

APA

Zhu, S., Fujita, D. J., & Wang, J. H. C. (2012). Inhibition of Lck: Evidence for a novel natural Src family kinase inhibitor. Journal of Enzyme Inhibition and Medicinal Chemistry, 27(4), 546–552. https://doi.org/10.3109/14756366.2011.601304

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free